Press release
$3.0 Bn, Pneumonia Testing Market (by 2030) Growth Forecast at 6.5% CAGR - Exclusive Report by Allied Market Research
Pneumonia Testing Market
The COVID-19 pandemic has had a positive impact on the pneumonia testing market. With a high number of COVID-19 cases worldwide, many individuals who contract the virus are also developing pneumonia, leading to a higher demand for diagnostic tests. Furthermore, the increased focus on research and development for the treatment of COVID-19-associated pneumonia is also driving growth in the market. As a result, the pneumonia testing market is expected to experience significant growth in the coming years.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Abott Laboratories, F.hoffman La roche, Thermofischer Inc, Hologic Inc, Biomerieux SA, Quidel Corporation, Bio Rad laborateries, Beckton and Dickinson Company, AdvanDx, Beckman Coulter
๐๐๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐จ๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ@https://www.alliedmarketresearch.com/request-sample/3776
The growth of the Pneumonia Testing Market is driven by various factors such as the increasing adoption of point-of-care testing, advancements in nucleic acid detection, growth in the geriatric population, and a rise in the prevalence of pneumonia among children globally. The increase in healthcare expenditure and the presence of advanced healthcare infrastructure, along with the availability of reimbursements and key market players, present significant growth opportunities for the market. However, the use of traditional methods such as cultures for detecting pneumonia causative organisms may slow down the market growth to some extent, as these methods are time-consuming and have a higher error rate.
โ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
The Pneumonia Testing Market can be segmented into two types:
Consumables: This segment includes reagents, kits, and other materials used in the testing process.
Analyzers: This segment includes equipment and instruments used for analyzing test samples in the detection of pneumonia. These instruments include point-of-care devices and laboratory-based analyzers.
๐๐ก๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ฆ๐๐ญ๐ก๐จ๐ ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ซ๐๐ ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐๐ฌ:
Molecular Diagnostics: This method involves the detection of genetic material (DNA or RNA) of the pathogen causing pneumonia.
Point of Care Testing (POCT): This method involves the use of rapid diagnostic tests that can be performed at the patient's bedside or in a primary care setting.
Immunodiagnostics: This method involves the detection of antibodies produced by the body in response to an infection, including pneumonia. It includes tests such as Enzyme-Linked Immunosorbent Assays (ELISAs) and Rapid Antigen Detection Tests (RADTs).
๐๐๐ค๐ ๐๐ง ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ @https://www.alliedmarketresearch.com/purchase-enquiry/3776
๐๐ก๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ข๐ง๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐๐ฌ:
Enzyme-Linked Immunosorbent Assay (ELISA): This is a widely used immunodiagnostic method for detecting the presence of specific antibodies in the blood.
Immunofluorescence: This technology uses fluorescence-labeled antibodies to detect the presence of specific antigens in a sample.
Western Blot: This technology is used to detect specific proteins in a sample and to identify their molecular weight.
Polymerase Chain Reaction (PCR): This technology is used to amplify specific DNA sequences, enabling the detection of low levels of the pathogen causing pneumonia.
Immunohistochemistry (IHC): This technology uses antibodies to detect the presence of specific antigens in tissue samples.
Others: This category includes other technologies used in pneumonia testing such as Rapid Antigen Detection Tests (RADTs), Microbial Culture, and Nucleic Acid Hybridization.
๐๐ก๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐๐ง๐-๐ฎ๐ฌ๐๐ซ ๐ข๐ง๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐๐ฌ:
Hospitals: This segment includes both inpatient and outpatient facilities that offer pneumonia testing services.
Diagnostic Laboratories: This segment includes independent and hospital-affiliated diagnostic labs that offer pneumonia testing services.
Homecare: This segment includes individuals who perform pneumonia tests at home using Point of Care (POC) testing devices.
Others: This segment includes other end-users such as nursing homes, clinics, and long-term care facilities.
๐๐ก๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง ๐ข๐ง๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐๐ฌ:
North America: This region includes the United States, Canada, and Mexico.
Europe: This region includes countries such as Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe.
Asia-Pacific: This region includes countries such as Japan, China, Australia, India, South Korea, and the rest of the Asia-Pacific region.
LAMEA: This region includes countries such as Brazil, Saudi Arabia, South Africa, and the rest of the Latin America, Middle East, and Africa region.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America has the highest Pneumonia Testing Market Share in 2020, owing to a rise in prevalence of chronic diseases, growth in healthcare expenditure, the surge in presence of advanced healthcare infrastructure, increase in the availability of reimbursements, and rise in presence of major market players in the region are the major factors driving the growth of the pneumonia testing market in North America.
๐๐ฎ๐ข๐๐ค๐ฅ๐ฒ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ@https://www.alliedmarketresearch.com/checkout-final/53f88224ae630f1431faa985b7875531
Contact:
David Correa
5933 NE Wi
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300n Sivers Drive
#205,โฏPortland, ORโฏ97220
United States
Hong Kong: +852-301-84916
Indiaโฏ(Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web:โฏhttps://www.alliedmarketresearch.com
Follow Us on:โฏLinkedInโฏTwitter
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies. This helps us dig out market data that helps us generate accurate research data tables and confirm utmost accuracy in our market forecasting. Every data company in the domain is concerned. Our secondary data procurement methodology includes deep presented in the reports published by us is extracted through primary interviews with top officials from leading online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release $3.0 Bn, Pneumonia Testing Market (by 2030) Growth Forecast at 6.5% CAGR - Exclusive Report by Allied Market Research here
News-ID: 3065294 • Views: โฆ
More Releases from Allied Market Research
Converting Paper Market Poised for Remarkable Growth, to Surpass USD 545.9 Billi โฆ
The global converting paper market was valued at $341.9 billion in 2023 and is projected to reach $545.9 billion by 2033, growing at a CAGR of 4.8% from 2024 to 2033. This growth is fueled by the increasing demand for customized paper products across various industries, including packaging, publishing, and e-commerce.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A10550
Converting paper refers to the process of transforming raw paperโฆ
![[2026] Trichlorosilane (TCS) Market Growing at a CAGR of 9.5% to 2033, Says AMR](https://cdn.open-pr.com/L/5/L526305139_g.jpg)
[2026] Trichlorosilane (TCS) Market Growing at a CAGR of 9.5% to 2033, Says AMR
Trichlorosilane (SiHCl3) is a silicon-based chemical compound with the molecular formula SiHCl3. It is a key intermediate in the production of silicon-based materials and is primarily used to manufacture polysilicon, which is the main component in solar cells and semiconductor devices. TCS is produced by the hydrochlorination of silicon tetrachloride (SiCl4) or by the reaction of silicon with hydrogen chloride. The global trichlorosilane market size was valued at $5.4 billionโฆ
Insights into the Gallic Acid Market Growth, Global Industry Forecast, 2033
Gallic acid (C7H6O5), also known as 3,4,5-trihydroxybenzoic acid, is a naturally occurring phenolic acid found in many plants, fruits, and natural substances like tea, grapes, berries, and oak bark. It is a secondary plant metabolite that plays a key role in plant defense mechanisms. The global gallic acid market was valued at $81.0 million in 2023, and is projected to reach $137.5 million by 2033, growing at a CAGR ofโฆ
![[2026] Insights into Single Crystal Diamond Market Trend, Strategies, Growth Opportunities, 2033](https://cdn.open-pr.com/L/5/L525566526_g.jpg)
[2026] Insights into Single Crystal Diamond Market Trend, Strategies, Growth Opp โฆ
A single crystal diamond is a diamond with a continuous and uninterrupted crystal lattice structure, free of grain boundaries or polycrystalline defects. Unlike polycrystalline diamonds, which have multiple small crystals fused together, single crystal diamonds have a perfect, uniform atomic arrangement. The global single crystal diamond market was valued at $1.5 billion in 2023, and is projected to reach $2.4 billion by 2033, growing at a CAGR of 4.7% fromโฆ
More Releases for Pneumonia
Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve โฆ
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903
With the rise of antibiotic resistance, aging populations, and increased use of ventilators inโฆ
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To โฆ
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies likeโฆ
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and currentโฆ
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lungโs air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -โฆ
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate hasโฆ
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For aโฆ
